Caricamento...

Targeting Functional Biomarkers in Schizophrenia with Neuroimaging

Many of the most debilitating symptoms for psychiatric disorders such as schizophrenia remain poorly treated. As such, the development of novel treatments is urgently needed. Unfortunately, the costs associated with high failure rates for investigational compounds as they enter clinical trials has l...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Curr Pharm Des
Autori principali: Wylie, Korey P., Smucny, Jason, Legget, Kristina T., Tregellas, Jason R.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4854787/
https://ncbi.nlm.nih.gov/pubmed/26818860
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !